![Xavier Reveles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xavier Reveles
Operationeel Directeur bij
BIOAFFINITY TECHNOLOGIES, INC.
Vermogen: 2 335 $ op 31-05-2026
Profiel
Mr. Xavier T.
Reveles is a Chief Operating Officer at bioAffinity Technologies, Inc., a Director-Cytogenetics Laboratory at University of Texas Health Science Center At San Antonio and a Member at Association for Molecular Pathology.
Mr. Reveles was previously employed as a Laboratory Director by Oncopath Laboratory.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-01-2025 | 1.398 ( 0,03% ) | 2 335 $ | 31-05-2026 |
Actieve functies van Xavier Reveles
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Operationeel Directeur | 01-01-2017 |
Association for Molecular Pathology
 Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Corporate Officer/Principal | - |
University of Texas Health Science Center At San Antonio
 University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Xavier Reveles
| Bedrijven | Functie | Einde |
|---|---|---|
Oncopath Laboratory | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
18
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Health Technology |
bioAffinity Technologies, Inc.
 bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
University of Texas Health Science Center At San Antonio
University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopath Laboratory |
Kies MarketScreener 
